Jason Amello's Net Worth
$2.54 Million
Who is Jason Amello?
Jason Amello has an estimated net worth of $2.54 Million. This is based on reported shares across multiple companies, which include TScan Therapeutics, Inc., GENZYME CORP, ZIOPHARM ONCOLOGY INC, Akebia Therapeutics, Inc., Acer Therapeutics Inc., and Candel Therapeutics, Inc..
SEC CIK
Jason Amello's CIK is 0001451805
Past Insider Trading and Trends
2022 was Jason Amello's most active year for acquiring shares with 5 total transactions. Jason Amello's most active month to acquire stocks was the month of January. 2011 was Jason Amello's most active year for disposing of shares, totalling 13 transactions. Jason Amello's most active month to dispose stocks was the month of March. 2017 saw Jason Amello paying a total of $481,650.00 for 86,500 shares, this is the most they've acquired in one year. In 2011 Jason Amello cashed out on 65,364 shares for a total of $3,512,819.70, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
TScan Therapeutics, Inc. (TCRX) Snapshot price: $5.55
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
GENZYME CORP No price found
CorpContrllr,ChiefAccntOfficer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -2.08K |
$74.00 | -$524,586.00 |
0
|
Apr 4
| |||
Form 4
|
—
|
0
|
$58.27 | -$159,758.40 | 3.27K |
Aug 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
| +15.87% | 1.04K |
$45.62 | -$24,315.46 | 7.61K |
May 24 - May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ZIOPHARM ONCOLOGY INC (TCRT) Snapshot price: $2.83
Executive Vice President & CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -10.49% | -2.62K |
$1.65 | -$4,327.95 | 22.38K |
May 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
∞
| 25K |
—
|
—
| 25K |
May 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Akebia Therapeutics, Inc. (AKBA) Snapshot price: $1.36
SVP, CFO & Treasurer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +18.93% | 23.02K |
$8.70 | -$60,691.20 | 144.64K |
Feb 28
| |||
Form 4
| -9.98% | -13.15K |
$7.70 | -$101,239.60 | 118.62K |
Apr 11
| |||
Form 4
| +97.35% | 65K |
—
|
—
| 131.77K |
Feb 28
| |||
Form 4
| -25.06% | -22.23K |
$8.94 | -$198,780.90 | 66.5K |
Dec 12
| |||
Form 4
| +28.79% | 19.5K |
—
|
—
| 87.24K |
Feb 28
| |||
Form 4
| +84.18% | 30K |
—
|
—
| 65.64K |
Feb 21
| |||
Form 4
| +354.71% | 26K |
—
|
—
| 33.33K |
Feb 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 6
| |||
Form 4
| +25.00% | 1K |
$13.22 | $13,220.00 | 5K |
Nov 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 4
|
∞
| 4K |
$17.00 | $68,000.00 | 4K |
Mar 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Acer Therapeutics Inc. (ACER) Snapshot price: $0.8675
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||